Literature DB >> 4871166

Target symptoms: a promising improvement criterion in psychiatric drug research.

P T Hesbacher, K Rickels, C Weise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4871166     DOI： 10.1001/archpsyc.1968.01740050083014

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  3 in total

1.  A placebo controlled trial of diazepam and oxprenolol for anxiety.

Authors:  G D Burrows; B Davies; L Fail; C Poynton; H Stevenson
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

2.  Development of a new tool for the assessment of patient-defined benefit in hospitalised older patients: the Patient Benefit Assessment Scale for Hospitalised Older Patients (P-BAS HOP).

Authors:  Maria Johanna van der Kluit; Geke J Dijkstra; Barbara C van Munster; Sophia De Rooij
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

3.  Scl-90-R symptom profiles and outcome of short-term psychodynamic group therapy.

Authors:  Hans Henrik Jensen; Erik L Mortensen; Martin Lotz
Journal:  ISRN Psychiatry       Date:  2013-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.